Dare Bioscience Stock (NASDAQ: DARE) stock price, news, charts, stock research, profile.
Open | $0.430 |
Close | $0.485 |
Volume / Avg. | 931.528K / 707.929K |
Day Range | 0.430 - 0.490 |
52 Wk Range | 0.270 - 1.060 |
Market Cap | $48.279M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 70 |
Short Interest | 0.29% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Dare Bioscience (NASDAQ: DARE) through any online brokerage.
Other companies in Dare Bioscience’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), CalciMedica (NASDAQ:CALC) and Ocuphire Pharma (NASDAQ:OCUP).
The latest price target for Dare Bioscience (NASDAQ: DARE) was reported by HC Wainwright & Co. on Wednesday, May 15, 2024. The analyst firm set a price target for 6.00 expecting DARE to rise to within 12 months (a possible 1150.00% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Dare Bioscience (NASDAQ: DARE) is $0.48 last updated May 17, 2024 at 7:26 PM EDT.
There are no upcoming dividends for Dare Bioscience.
Dare Bioscience’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Dare Bioscience.
Dare Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.